Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
111,247
datasets available to search
ShareScore release 0.9.0
Dataset results
111,247 results for “cells”
Chromatin accessibility landscape of mouse early embryos revealed by single-cell NanoATAC-seq2
<p>The chromatin accessibility assay using scNanoATAC-seq2 was conducted on the Oxford Nanopore (ONT) long-read sequencing platform and focused on samples related to mouse preimplantation development. These samples included preimplantation embryos, ranging from the zygote to the late blastocyst, as well as oocytes, granulosa cells, and naive mouse embryonic stem cells. The embryos were derived from crosses of C57xDBA, DBAxC57, and C57xCAST. Additionally, cell lines from humans and mice were assayed during the technical testing phase.</p> <p> </p> <p><strong>Note: </strong>In this dataset, 'pre-TE' denotes early trophectoderm (early TE), while 'TE' signifies late trophectoderm (late TE), as outlined in the main article.</p>
code and datasets for "GP73 reinforces cytotoxic T-cell function by regulating HIF-1α and increasing antitumor efficacy"
<p>We utilized T-cell-specific GP73 knockout mice to establish MC38 and B16 tumor models to investigate the impact of GP73-deficient T cells on tumor growth. Single-cell sequencing was subsequently employed to classify tumor-infiltrating immune cells and assess changes in cytokines and metabolic genes. Through RNA sequencing, real-time quantitative PCR, western blotting, flow cytometry, seahorse analysis, glucose uptake, and lactate secretion assays, we explored how GP73 regulates HIF-1α to influence T-cell antitumor functionality. Furthermore, we established adoptive transfer experiments to study the ability of GP73-overexpressing T cells to combat tumors. Clinical tumor patient blood samples were collected to assess the relationship between immunotherapy efficacy and T-cell GP73 levels.</p>
Data set: Modeling of Magnesium Intercalation into Chevrel Phase Mo6S8: Report on improved cell design.
<p>Dataset of the continuum simulations generated and used within the paper "<span>Modeling of Magnesium Intercalation into Chevrel Phase Mo</span><span>6</span><span>S</span><span>8</span><span>: Report on improved cell design</span>", published in <span>Batteries & Supercaps</span><br> (<span>2023</span><span>, </span><span>6 (5)</span><span>, e202200562</span>, DOI: <span>10.1002/batt.202200562</span>).</p> <p><span>A good understanding of the limiting processes in rechargeable magnesium batteries is key to develop novel highcapacity/high-voltage cathode materials. Thereby, the performance of magnesiumion batteries can strongly depend on the morphology of the intercalation cathode. Moreover, high mass loadings are essential for commercialization. In this work the influence of different mass loadings are studied in addition to the impact of the particle size distribution of the active material. Therefore, a detailed continuum model is developed, which is able to describe the complex intercalation of magnesium into a Chevrel phase (CP) cathode. The model considers the thermodynamics, kinetics and interplay of the two energetically different intercalation sites of Mo</span><span>6</span><span>S</span><span>8</span><span>, which results from its unique crystal structure, as well as the impact of the desolvation on the electrochemical reactions and possible ion agglomeration. Ideal combinations of mass loading and electrolyte concentration as well as the desired CP particle size are determined for the state-of-the-art magnesium tetrakis(hexafluoroisopropyloxy)borate Mg[B(hfip)</span><span>4</span><span>]</span><span>2 </span><span>electrolyte.</span> </p>
Fig. 4. MCF-7 in Ethanolic extract of Mimosa caesalpiniifolia leaves: Chemical characterization and cytotoxic effect on human breast cancer MCF-7 cell line
Fig. 4. MCF-7 cell diameter (μm) after treatment with cyclophosphamide (CP, 550 μg/mL) and different concentrations (5.0–320.0 μg/mL) of the ethanolic extract of Mimosa caesalpiniifolia leaves (EEM) for 24 or 48 h, compared to the negative control cells (NC). Results are expressed as mean ± SEM of three independent experiments. Different letters indicate significant differences (p <0.01) by the Tukey test. Note cell-diameter reduction after treatment, in comparison to the negative control cells, thereby indicating EEM cytotoxicity.
Single Cell HTAN SCLC
<p>These data include a subset of single-cell samples from the CPTAC Glioblastoma data processed using the following steps:</p> <ol> <li>Ensembl gene ID's were matched to HGNC symbols, chromosome name, starting position, and ending position via Biomart using the <em>scater</em> R package.</li> <li>Size factors were computed using the <em>scran</em> R package.</li> <li>UMAP dimensions were computed using the <em>scater</em> R package.</li> <li>Probes without matching HGNC symbols were removed.</li> <li>Where duplicate HGNC symbols were present, the gene with the maximum normalized range was retained.</li> <li>Cell types were inferred using the <em>scMRMA</em> R package.</li> <li>Cells with less than or equal to 1,000 features were removed.</li> <li>Cells with mitochondrial reads greater than or equal to 50% were removed.</li> <li>Expression data for each cell type were saved separately for each sample.</li> <li>For macrophages for each sample, a differentiation trajectory was estimated using the <em>monocle3</em> R package, and plots were colored by combined expression of the M0 markers CSF1R, CD14, CD68, and CD11B, the M1 markers CD86, MARC0, CXCL9, CXCL10, CXCL11, NOS2, SOCS1, and CD64, and the M2 markers TGM2, CD23, ARG1, CCL22, CD163, and CD206 (from PMC8268869). Pseudotime starting points were annotated in <em>monocle3</em> using visual inspection of plots. Only samples in which a visible trajectory from M0 -> M1 -> M2 was evident using these markers were retained.</li> <li>For B cells and T cells for each sample, a differentiation trajectory was estimated using the <em>monocle3</em> R package, and plots were colored by combined expression of the B cell and T cell differentiation markers TCF3, FOXO1, EBF1, and PAX5 and TCF3, NOTCH1, HES1, TCF7, TLE3, TLE6, BCL11B, and GATA3, respectively (from PM<span><span>24679436</span></span>). Pseudotime starting points were annotated in <em>monocle3</em> using visual inspection of plots. Only samples in which a visible trajectory of dedifferentiation was evident using these markers were retained.</li> <li>For endothelial cells for each sample, a differentiation trajectory was estimated using the <em>monocle3</em> R package, and plots were colored by combined expression of the endothelial cell differentiation markers GATA2, FLI1, SOX7, SOX18 (from PM<span><span>28334937</span></span>). Pseudotime starting points were annotated in <em>monocle3</em> using visual inspection of plots. Only samples in which a visible trajectory of dedifferentiation was evident using these markers were retained.</li> <li>For fibroblasts for each sample, a differentiation trajectory was estimated using the <em>monocle3</em> R package, and plots were colored by combined expression of fibrogenesis markers TGFB1, FGF2, ANGPT1, ANGPT2, PDGFA, PDGFB, PDGFC, PDGFD, VEGFA, and VEGFB (from PM<span><span>17280897</span></span>). Pseudotime starting points were annotated in <em>monocle3</em> using visual inspection of plots. Only samples in which a visible trajectory of dedifferentiation was evident using these markers were retained.</li> <li>For NK cells for each sample, a differentiation trajectory was estimated using the <em>monocle3</em> R package, and plots were colored by combined expression of transmembrane proteins that mediate cytotoxicity, FASLG and TNFSF10 (from PM31107565). Pseudotime starting points were annotated in <em>monocle3</em> using visual inspection of plots. Only samples in which a visible trajectory of dedifferentiation was evident using these markers were retained. These pseudotime assignments (and other cell type assignments) are available from <strong>HTAN_SCLC_pseudotime.zip.</strong></li> <li>For all cell types for each sample, 5-fold cross-validation matrices for expression, PCA, and pseudotime were generated across 1 random split, for a total of 5 files per cell type, per sample. These files are available from <strong>HTAN_SCLC_expression.zip.</strong></li> </ol>
Single cell deletion of the transcription factors Trps1 and Sox9 reveals novel functions in adult cortical astrocytes
Open the record for dataset details and reuse information.
Data from: Cell proliferation and migration during early development of a symbiotic scleractinian coral
In scleractinian reef-building corals, patterns of cell self-renewal, migration and death remain virtually unknown, limiting our understanding of cellular mechanisms underlying initiation of calcification, and ontogenesis of the endosymbiotic dinoflagellate relationship. In this study we pulse-labeled the coral Stylophora pistillata for 24 h with BrdU at four life stages (planula, early metamorphosis, primary polyp, and adult colony) to investigate coral and endosymbiont cell proliferation during development, while simultaneously recording TUNEL-positive, i.e. apoptotic, nuclei. In the primary polyp, the fate of BrdU-labeled cells was tracked during a 3 days chase. The pharynx and gastrodermis were identified as the most proliferative tissues in the developing polyp, and BrdU-labeled cells accumulated in the surface pseudostratified epithelium and the skeletogenic calicodermis during the chase, revealing cell migration to these epithelia. Surprisingly, the lowest cell turnover was recorded in the calicodermis at all stages, despite active, ongoing skeletal deposition. In dinoflagellate symbionts, DNA synthesis was systematically higher than in coral host gastrodermis, especially in planula and early metamorphosis. The symbiont to host cell ratio remained however constant, indicating successive post-mitotic control mechanisms by the host of its dinoflagellate density in early life stages, increasingly shifting to apoptosis in the growing primary polyp.
Data from: Monocyte recruitment to the dermis and differentiation to dendritic cells increases the targets for Dengue virus replication
Dengue virus (DENV) causes the most prevalent arthropod-borne viral disease in humans. Although Aedes mosquitoes transmit DENV when probing for blood in the skin, no information exists on DENV infection and immune response in the dermis, where the blood vessels are found. DENV suppresses the interferon response, replicates, and causes disease in humans but not wild-type mice. Here, we used mice lacking the interferon-α/β receptor (Ifnar–/–), which had normal cell populations in the skin and were susceptible to intradermal DENV infection, to investigate the dynamics of early DENV infection of immune cells in the skin. CD103+ classical dendritic cells (cDCs), Ly6C– CD11b+ cDCs, and macrophages in the steady-state dermis were initial targets of DENV infection 12-24 hours post-inoculation but then decreased in frequency. We demonstrated recruitment of adoptively-transferred Ly6Chigh monocytes from wild-type and Ifnar–/– origin to the DENV-infected dermis and differentiation to Ly6C+ CD11b+ monocyte-derived DCs (moDCs), which became DENV-infected after 48 hours, and were then the major targets for virus replication. Ly6Chigh monocytes that entered the DENV-infected dermis expressed chemokine receptor CCR2, likely mediating recruitment. Further, we show that ~100-fold more hematopoietic cells in the dermis were DENV-infected compared to Langerhans cells in the epidermis. Overall, these results identify the dermis as the main site of early DENV replication and show that DENV infection in the skin occurs in two waves: initial infection of resident cDCs and macrophages, followed by infection of monocytes and moDCs that are recruited to the dermis. Our study reveals a novel viral strategy of exploiting monocyte recruitment to increase the number of targets for infection at the site of invasion in the skin and highlights the skin as a potential site for therapeutic action or intradermal vaccination.
Data from: Modelling of dysregulated glucagon secretion in type 2 diabetes by considering mitochondrial alterations in pancreatic alpha cells
Type 2 diabetes mellitus (T2DM) has been associated with insulin resistance and the failure of β-cells to produce and secrete enough insulin as the disease progresses. However, clinical treatments based solely on insulin secretion and action have had limited success. The focus is therefore shifting towards α-cells, in particular to the dysregulated secretion of glucagon. Our qualitative electron-microscopy-based observations gave an indication that mitochondria in α-cells are altered in Western-diet-induced T2DM. In particular, α-cells extracted from mouse pancreatic tissue showed a lower density of mitochondria, a less expressed matrix, and a lower number of cristae. These deformities in mitochondrial ultrastructure imply a decreased efficiency in mitochondrial ATP production, which prompted us to theoretically explore and clarify one of the most challenging problems associated with T2DM, namely the lack of glucagon secretion in hypoglycemia and its oversecretion at high blood glucose concentrations. To this purpose, we constructed a novel computational model that links α-cell metabolism with their electrical activity and glucagon secretion. Our results show that defective mitochondrial metabolism in α-cells can account for dysregulated glucagon secretion in T2DM, thus improving our understanding of T2DM pathophysiology and indicating possibilities for new clinical treatments.
Immunotherapy-mediated thyroid dysfunction: genetic risk and impact on outcomes with PD-1 blockade in non-small cell lung cancer
<p>Polygenic risk score weights derived using LDpred for hypothyroidism and thyroid medication use.</p>
miRNA149 as candidate for facial clefting and neural crest cell migration: Appendix data
<p>Appendix Data for the paper "<strong>miRNA149 as candidate for facial clefting and neural crest cell migration</strong>" by Stüssel et al.</p> <p>Appendix Table S1: Overview of candidate microRNAs expressed in human neural crest cells</p> <p>Appendix Table S2: nsCL/P associated candidate variants colocalizing with candidate miRNAs</p> <p>Appendix Table S3: Overview of Differentially Expressed genes</p> <p>Appendix Table S4: Overview of GO-gene sets enriched in pathway analysis</p> <p>Appendix Table S5: GO-Terms of pathway enrichment analysis with term-level 5 and group size <100</p>
A novel mitochondrial Kv1.3-caveolin axis controls cell survival and apoptosis
<p>The voltage-gated potassium channel Kv1.3 plays an apparent dual physiological role by participating in activation and proliferation of leukocytes as well as promoting apoptosis in several types of tumor cells. Therefore, Kv1.3 is considered a potential pharmacological target for immunodeficiency and cancer. Different cellular locations of Kv1.3, at the plasma membrane or the mitochondria, could be responsible for such duality. While plasma membrane Kv1.3 facilitates proliferation, the mitochondrial channel modulates apoptotic signaling. Several molecular determinants of Kv1.3 drive the channel to the cell surface, but no information is available about its mitochondrial targeting. Caveolins, which are able to modulate cell survival, participate in the plasma membrane targeting of Kv1.3. The channel, via a caveolin-binding domain (CDB), associates with caveolin 1 (Cav1), which localizes Kv1.3 to lipid raft membrane microdomains. The aim of our study was to understand the role of such interactions not only for channel targeting but also for cell survival in mammalian cells. By using a caveolin association-deficient channel (Kv1.3 CDB<i><sub>less</sub></i>), we demonstrate here that while the Kv1.3-Cav1 interaction is responsible for the channel localization in the plasma membrane, a lack of such interaction accumulates Kv1.3 in the mitochondria. Kv1.3 CDB<i><sub>less</sub></i> severely affects mitochondrial physiology and cell survival, indicating that a functional link of Kv1.3 with Cav1 within the mitochondria modulates the pro-apoptotic effects of the channel. Therefore, the balance exerted by these two complementary mechanisms fine-tune the physiological role of Kv1.3 during cell survival or apoptosis. Our data highlight an unexpected role for the mitochondrial caveolin-Kv1.3 axis during cell survival and apoptosis.</p>
Supplemental tables for: A periventricular gradient of innate immune cell activation in Multiple Sclerosis
<p><span><span><span><span><span><span><span><span><span><span><span><b>Objectives:</b> To explore <i>in-vivo</i> innate immune cell activation as a function of the distance from ventricular CSF in patients with Multiple Sclerosis (MS) using [18F]-DPA714 PET, and to investigate its relationship with periventricular microstructural damage, evaluated by magnetization transfer ratio (MTR), and with trajectories of disability worsening.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>Methods: </b>Thirty-seven MS patients and nineteen healthy controls underwent MRI and [18F]-DPA714 TSPO dynamic PET, from which individual maps of voxels characterized by innate immune cell activation (DPA+) were generated. White matter (WM) was divided in 3mm-thick concentric rings radiating from the ventricular surface toward the cortex, and the percentage of DPA+ voxels and mean MTR were extracted from each ring. Two-year trajectories of disability worsening were collected to identify patients with and without recent disability worsening.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>Results: </b>The percentage of DPA+ voxels was higher in patients compared to controls in the periventricular WM (<span><span>p=6.10e-6</span></span>), and declined with increasing distance from ventricular surface, with a steeper gradient in patients compared to controls (<span><span>p=0.001</span></span>). This gradient was found both in periventricular lesions and normal-appearing WM. In the total WM, it correlated with a gradient of microstructural tissue damage measured by MTR (<span><span>r<sub>s</sub>=-0.65, p=1.0e-3</span></span>). When compared to clinically stable patients, patients with disability worsening were characterized <span><span>by a higher percentage of DPA+ voxels </span></span>in the periventricular normal-appearing WM (<span><span>p=0.025</span></span>).</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>Conclusions: </b>Our results demonstrate that in MS the innate immune cell activation predominates in periventricular regions and associates with microstructural damage and disability worsening. This could result from the diffusion of pro-inflammatory CSF-derived factors into surrounding tissues.</span></span></span></span></span></span></span></span></span></span></span></p>
Passivating polysilicon recombination junctions for crystalline silicon solar cells
<p>Data underlying the publication</p>
Activation markers plotted against nutrient sensors in CD4+ and CD8+ T-cells.
<p>Activation markers (CD69, CD25, CD71, and CD38) plotted against nutrient sensors (GLUT1, GLUT4, HK1, HK2, and CD36) in CD4+ T-cells.</p>
Data from: Reducing complexity and unidentifiability when modelling human atrial cells
<p>Mathematical models of a cellular action potential in cardiac modelling have become increasingly complex, particularly in gating kinetics which control the opening and closing of individual ion channel currents. As cardiac models advance towards use in personalised medicine to inform clinical decision- making, it is critical to understand the uncertainty hidden in parameter estimates from their calibration to experimental data. This study applies approximate Bayesian computation to re-calibrate the gating kinetics of four ion channels in two existing human atrial cell models to their original datasets, providing a measure of uncertainty from the parameter posterior distributions. Two approaches are investigated to reduce the uncertainty present: firstly to re-calibrate the models to a more complete 'unified' dataset and, secondly, the use of a standardised formulation with fewer parameters to constrain. The study shows that the use of more complete datasets does not eliminate uncertainty present in parameter estimates. The standardised model, particularly for the fast sodium current, shows reduced residuals from experimental data alongside lower parameter uncertainty and improved performance.</p>
FIGURE 1. Bryoerythrophyllum subcaespitosum. A. Habit, dry. B–D. Leaves. E. Perichaetial leaf. F. Leaf apex. G. Basal laminal cells. H. Perichaetial leaf margin. I. Upper laminal cells. J–M in Bryoerythrophyllum subcaespitosum (Pottiaceae), a new combination for a neglected species from South America
FIGURE 1. Bryoerythrophyllum subcaespitosum. A. Habit, dry. B–D. Leaves. E. Perichaetial leaf. F. Leaf apex. G. Basal laminal cells. H. Perichaetial leaf margin. I. Upper laminal cells. J–M. Cross-sections of the leaf. N. Peristome. O. Cross-section of stem. Scale bars: A = 0.1 cm. B–E = 0.2 mm. F, H, N = 50 µm. G = 60 µm. I = 20 µm. J, K, L, M = 40 µm. O = 25 µm. A–C, F, G, I–M, O from Cano et al. 5149, MUB; D, E, H, N from Lindig 2008, BM.
Engineered acetoacetate-inducible whole-cell biosensors based on the AtoSC two-component system
<p>Data and code for manuscript.</p>
Rewiring of endogenous signaling pathways to genomic targets for therapeutic cell reprogramming
<p>Data underlying the figures in the publication “Rewiring of endogenous signaling pathways to genomic targets for therapeutic cell reprogramming”, published in <em>Nat Commun</em>, <strong>2020</strong>, 11, 608. <a href="https://www.nature.com/articles/s41467-020-14397-8">https://www.nature.com/articles/s41467-020-14397-8</a></p> <p>Table of contents:</p> <p><strong>1. Source Data</strong>; Excel file with the data for <em>Figures 2, 3b, 3d, 3c, 4a, 4b, 4c, 5</em> as well as <em>S2, S3, S4, S5, S6, S7a, S7b, S8, S9, S10, S11, S12, S13a</em> and <em>S13b</em>.</p> <p><strong>Data 1 – Transgene expression by SEAP</strong></p> <p>Data for <em>Figures 2, S2, S4, S5, S7a, S8, S9, S12</em> and <em>S13b</em>.</p> <p>SEAP (human placental secreted alkaline phosphatase) levels were profiled in cell culture supernatants using a colorimetric assay. 100 µL 2x SEAP assay buffer (20 mM homoarginine, 1 mM MgCl2, 21% diethanolamine, pH 9.8) was mixed with 80 µL heat-inactivated (30 min at 65 °C) cell culture supernatant. After the addition of 20 µL substrate solution (120 mM p-nitrophenyl phosphate; cat. no. AC128860100, Thermo Fisher Scientific, Waltham, MA, USA), the absorbance time course was recorded at 405 nm and 37 °C using a Tecan Genios PRO plate reader (cat. no. P97084; Tecan Group AG, Maennedorf, Switzerland) and the SEAP levels were determined as follows: first, absorbance change over time (slope) was calculated. According to the Beer–Lambert’s law, absorbance is proportional to the concentration of a colored compound and depends on the light path length (d) and extinction coefficient (ε) (ε for p-nitrophenyl (εpNP) = 18.600 M−1 cm−1). Enzymatic activity EA [U/L] was calculated from the equation: EA = slope × dilution factor × εpNP−1 × d−1</p> <p>Values in the file present determined SEAP levels.</p> <p><strong>Data 2 – Endogenous gene expression by qPCR</strong></p> <p>Data for <em>Figures 3b, 3d, 4a, 4b, 5, S3, S6, S10, S11</em> and <em>S13a</em>.</p> <p>Total RNA of HEK293T cells was isolated using the Quick-RNA kit (Zymo Research, Irvine, CA, USA). Reverse transcription was performed using a High-Capacity cDNA Reverse Transcription Kit (cat. no. 4368814, Thermo Fisher Scientific, Waltham, MA, USA). Quantitative PCR was performed with the SsoAdvanced Universal SYBR® Green Supermix (cat. no. 1725270, Bio-Rad, Hercules, CA, USA). The Eppendorf Realplex Mastercycler (Eppendorf GmbH) was set to the following amplification parameters: 30 s at 95 °C and 40 cycles of 15 s at 95 °C followed by 30 s at X °C (X = 59 for insulin, 64 for IL-12, 59 or 64 for GAPDH). The relative threshold cycle (Ct) was determined and normalized to the endogenous glyceraldehyde 3-phosphate dehydrogenase (GAPDH) transcript. The fold change for each transcript relative to the control was calculated using the comparative Ct method.</p> <p>Values in the file present determined mRNA levels relative to GAPDH.</p> <p><strong>Data 3 – Secreted protein level by ELISA</strong></p> <p>Data for <em>Figures 3c</em> and <em>4c</em>.</p> <p>Human Insulin was quantified with the Mercodia Insulin ELISA (cat. no. 10-1113-01, Mercodia, Uppsala, Sweden). IL-12 was quantified with the human IL-12 (p40) ELISA Kit (cat. no. KAC1561, Thermo Fisher Scientific, Waltham, MA, USA).</p> <p>Values in the file present protein levels as determined by ELISA kit.</p> <p><strong>Data 4 – Nanoluc luciferase</strong></p> <p>Data for <em>Figure S7b</em>.</p> <p>NanoLuc® luciferase was quantified in cell culture supernatants using the Nano-Glo® Luciferase Assay System (cat. no. N1110; Promega, Duebendorf, Switzerland). In brief, 7.5 µL of cell culture supernatant was added per well of a black 384-well plate and mixed with 7.5 µL substrate-containing assay buffer. Total luminescence was quantified using a Tecan Genios PRO plate reader (Tecan Group AG).</p> <p>Values in the file present luminescence as measured.</p>
Data from: GATA2 controls lymphatic endothelial cell junctional integrity and lymphovenous valve morphogenesis through miR-126
Mutations in the transcription factor GATA2 cause lymphedema. GATA2 is necessary for the development of lymphatic valves (LVs) and lymphovenous valves (LVVs), and for the patterning of lymphatic vessels. Here, we report that GATA2 is not necessary for valvular endothelial cell (VEC) differentiation. Instead, GATA2 is required for VEC maintenance and morphogenesis. GATA2 is also necessary for the expression of cell junction molecules VE-Cadherin and Claudin5 in lymphatic vessels. We identified miR-126 as a target of GATA2, and miR-126-/- embryos recapitulate the phenotypes of mice lacking GATA2. Primary human lymphatic endothelial cells (HLECs) lacking GATA2 (GATA2ΔHLEC) have altered expression of Claudin5 and VE-Cadherin, and blocking miR-126 activity in HLECs phenocopies these changes in expression. Importantly, overexpression of miR-126 in GATA2ΔHLEC significantly rescues the cell junction defects. Thus, our work defines a new mechanism of GATA2 and uncovers miR-126 as a novel regulator of mammalian lymphatic vascular development.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.